FILTER
FILTERED ARTICLE RESULTS
Finding Funding: The Diversification of the Biotech Financing Landscape
March 27, 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.
The Winning Formula: Building the Number One Biopharmaceutical Supercluster
February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
Quality: A Means for Value Creation
June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
Innovation: The Industry’s Backbone
May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.
Logistics and Distribution: From Factory to Patient
May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.
Paying the Price: U.S. Biopharma Industry
March 17, 2017
Slashing drug prices might benefit patients in the short term, but at what cost?
Pooling Its Force: U.S. Biopharmaceutical Industry Channels R&D Focus Amid Changing Tides
March 01, 2017
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
USA Mining 2025-26 - Pre-release
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
